Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
Among patients with previously untreated advanced renal-cell carcinoma, treatment with pembrolizumab plus axitinib resulted in significantly longer overall survival and progress...